Biotech company Regeneron to buy bankrupt 23andMe for $256M
Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to…
Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to…